Centrus Energy LEU 深 滬
等待開盤 12-19 09:30:00 美东时间
229.68
+8.590
+3.89%
華盛通- 最 高237.97
- 今 開227.61
- 成交量 86.15万股
- 最 低 220.50
- 昨 收 221.09
- 總市值 41.83亿
- 52周最高 464.25
- 市盈率 靜 51.37
- 換手率 4.73%
- 52周最低 49.4001
- 委 比 -60.00%
- 總股本 1821.20万
- 歷史最高 464.25
- 量 比 0.92
- 振 幅 7.90%
- 歷史最低 1.00
- 每 手 1
- 風險率 98.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Top YTD best-performing coal and consumable fuels companies
Oil prices (CL1:COM) were in the spotlight on Wednesday after a flare-up in tensions between the U.S. and Venezuela. In light of the development, Seeking Alpha took a look at the energy sector's perfo...
12-18 03:53
Shares of uranium and nuclear-linked stocks are trading lower. The industry may be experiencing weakness amid reports that some of Oracle's data centers for OpenAI were delayed.
Shares of uranium and nuclear-linked stocks are trading lower. The industry may...
12-13 02:41
美股大行评级 | 高盛上调梅西百货目标价至22美元！ 摩根大通上调美国铝业公司目标价至45美元
今日重点评级关注：Stifel：维持X4 Pharmaceuticals"买入"评级，目标价从7.5美元升至10美元；花旗：维持UP Fintech Holding"买入"评级，目标价从17.4美元升至17.5美元
12-08 08:34
Shares of uranium and nuclear-related stocks are trading higher on reports indicating the US plans to take more stakes in critical minerals companies.
Shares of uranium and nuclear-related stocks are trading higher on reports indi...
12-05 04:46
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
11-26 10:07
UBS Maintains Neutral on Centrus Energy, Raises Price Target to $245
UBS analyst Jon Windham maintains Centrus Energy (AMEX:LEU) with a Neutral and raises the price target from $215 to $245.
11-26 01:57
DOE Official Says U.S. Plans To Own Up To 10 New Nuclear Reactors
- Reuters Citing DOE Official
11-20 01:48
Looking Into Centrus Energy Corp's Recent Short Interest
Centrus Energy Corp's (NYSE:LEU) short interest as a percent of float has risen...
11-19 01:00
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
